glp-1 medications zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly Zepbound Vial: What You Need

in patients experiencing adverse events, 96% had mild to moderate GI side effects, while approximately 4% had severe nausea or vomiting

Zepbound is not FDA-approved for prediabetes or metabolic syndrome

When prescribed appropriately and monitored by a licensed provider, they are generally well tolerated

I thought, Im not that sick, says the 41-year-old Florida behavioral analyst

Its like a little bit a little bit

GLP-1 injectables may be considered when you meet BMI criteria (typically 30 or higher, or 27 or higher with weight-related health conditions), you are comfortable with weekly self-injection, and your health profile does not include contraindications for GLP-1 medications